Additional study demonstrated that more than 50% of JAK2 mutation positive MPN transforms into JAK2 mutation negative AML and is associated with much shorter interval between MPN diagnosis and leukemia transformation (3 versus 10 years) [17–20]. Here, JAK2 is linked to myeloproliferative disorder.